NAS:MGNX (USA) Also Trade In: Germany

Macrogenics Inc $ 30.52 -0.16 (-0.52%)

Volume:
423,168
Avg Vol (1m):
1,916,928
Market Cap $:
1.50 Bil
Enterprise Value $:
1.36 Bil
P/E (TTM):
0.00
P/B:
7.87
Warning! GuruFocus has detected 3 Severe warning signs with MGNX. Click here to check it out.
5D 3M YTD 1Y 5Y 10Y All 1Y (-%)

MGNX News and Headlines - Macrogenics

GuruFocus Articles Total 11
  • 1

Stock soars on promising early trial data for key drugs

The price of MacroGenics Inc. (MGNX) shares has recently seen a huge jump. After providing an early glimpse of some of the earnings results on May 6, MacroGenics’s stock soared by more than 230% to a two-year high, bringing its market value to nearly $1 billion.

More information on the drugs being studied will be released this week in the form of abstracts. However, in my opinion, we will need to wait for the American Society of Clinical Oncology (aka ASCO) meeting on May 29 to 31 to see whether the increase is justified. At

275 Views    Barry Cohen    2020-05-11 14:14
The company's management has gone ahead with a public offering to take advantage of the recent spike after good trial results of its key drug, margetuximab

There are dozens of listed biotech and pharmaceutical companies with scant revenues that have managed to carry out public offerings to raise funding purely for research. But few of these companies have pipelines with drugs that have managed to reach Phase 3 trials and continued to deliver promising results. MacroGenics Inc. (MGNX) is a classic example of one such company. With the recent spike in its stock price, and its upcoming offering, the stock is an excellent subject of analysis.

A very promising pipeline

MacroGenics is at pivotal phase in terms of its research. The clinical stage biopharmaceutical company, which

32 Views    Ishan Majumdar    2019-02-13 17:20
The company already had a dominant position in the fast-growing gene sequencing market before strengthening its position with the acquisition of Pacific Biosciences

The stock traded well above $300 before the recent downturn. It has a price-earnings ratio of nearly 70 and a lofty valuation of more than $45 billion. Its price has tripled in the past five years and is up more than 50% from its 52-week low, owing in part to renewed enthusiasm for the biotechnology industry. Does it warrant a look, or even your investment dollars?

It does if it’s Illumina Inc. (ILMN). The San Diego-based gene sequencing company is an American success story. Only 30 years old, it pretty much owned the gene sequencing market when it recently added

85 Views    Barry Cohen    2018-11-13 19:32
Akebia Therapeutics, Macrogenics on the list

According to the GuruFocus All-In-One Screener, the following health care stocks are popular among gurus.

Three gurus are invested in Akebia Therapeutics Inc. (AKBA).

The company designs, manufactures and commercialize novel therapeutics to patients with kidney disease through hypoxia-inducible factor (HIF) biology. It has a market cap of $589.31 million.

The stock is trading with a price-book (P/B) ratio of 2.55. The current price of $10.36 is 48.84% below its 52-week high and 16.01% above its 52-week low. Over the past 10 years, it has returned a loss of 61%.

The company’s largest shareholder among the gurus is

158 Views    Tiziano Frateschi    2018-05-27 16:55
These stocks have positions in gurus' portfolios

According to the GuruFocus All-In-One Screener, the following health care stocks are popular among gurus.

Four gurus are invested in Zimmer Biomet Holdings Inc. (ZBH).

The medical device company has a market cap of $21.81 billion. Its revenue has grown 8.9% annually over the past 10 years.

The stock is trading with a price-earnings (P/E) ratio of 12.08. The current price of $107.70 is 10.65% below its 52-week high and 2.39% above its 52-week low. Over the past 10 years, it has returned a gain of 37%.

The company’s largest shareholder among the gurus is Jana Partners

303 Views    Tiziano Frateschi    2018-04-06 15:09
Here's a look at the structure of the Incyte-Macrogenics transaction and why it's important for the companies on either side

Incyte Corp. (INCY) just announced a fresh deal with small-cap biotechnology company MacroGenics Inc. (MGNX), and both companies are picking up some strength on the back of the news. MacroGenics traded at a close to 20% premium to its preannouncement market capitalization Wednesday morning. Incyte was up a couple of percentage points, having spiked in the early session but subsequently settled down.

This gain might not seem as substantial of the form, but when you consider the size of Incyte compared to that of MacroGenics, it's a solid market response to the development.

In light of this response, then, here

68 Views    George Ronan    2017-10-25 19:07
Gurus' holdings with falling prices and returns

While gurus hold positions in these companies, the stock price and returns continue to fall. These are the worst-performing stocks over the last three months with a long-term presence in more than three gurus’ portfolios.

Seattle Genetics Inc. (SGEN) had a negative performance of 21.9% over the last six months. Three mutual funds hold the stock with a total weight of 0.02% on their portfolios.

1268849855.png

The company has a market cap of $7.64 billion, and the stock is trading with a price-sales (P/S) ratio of 17.68. The price of $53.4 is 29.14%

150 Views    Tiziano Frateschi    2017-09-15 20:03
These companies had a negative 6-month performance

While gurus hold positions in these companies, the stock price and returns continue to fall. These are the worst-performing stocks over the last three months with a long-term presence in more than four gurus’ portfolios.

United Rentals Inc. (URI) had a negative performance of 9.5% over the last six months. Five mutual funds hold the stock with a total weight of 1.75% on their portfolios.

The company has a market cap of $9.72 billion, and the stock is trading with a price-sales (P/S) ratio of 1.65. The price of $115.03 is 14.34% below its 52-week high and 62.98% above

320 Views    Tiziano Frateschi    2017-08-04 20:40
The hedge fund guru's largest 3rd-quarter sales

Julian Robertson (Trades, Portfolio) is considered the father of the hedge fund. He launched his firm Tiger Management in 1980 with $8 million and turned it into over $22 billion in the late 1990s. During the third quarter the guru’s largest sells were the following:

He reduced his stake in Delta Air Lines Inc. (DAL) by 82.11% with an impact of -5.58% on the portfolio.

The company provides scheduled air transportation for passengers and cargo throughout the U.S. and around the world. The company's business segments are airline and refinery. Third-quarter operating revenue decreased 5.6% with

416 Views    Tiziano Frateschi    2016-12-07 19:28
Largest sales by investor during second quarter

Ronald Muhlenkamp (Trades, Portfolio) is the founder and president of Muhlenkamp & Company Inc. and portfolio manager for the company's self-named mutual fund (MUHLX). The following are his largest sales of the second quarter.

The investor closed his stake in Baker Hughes Inc. (BHI), with an impact of -1.99% on the portfolio.

The company operates in the oilfield services industry. It provides products and services for drilling and evaluation of oil and gas wells, completion and production of oil and gas wells, fluids and chemicals and reservoir technology.

Second quarter revenue decreased 10% from the first

1335 Views    Tiziano Frateschi    2016-08-15 19:19

According to GuruFocus list of three-year lows, Knowles Corporation, Macrogenics Inc., MiX Telematics Ltd. and Education Management Corp have all reached their three-year lows.

Knowles Corporation (KN) Reached the Three-Year Low of $28.68

The prices of Knowles Corporation (KN) shares have declined to close to the three-year low of $28.68, which is 18.2% off the three-year high of $33.66.

Knowles Corporation has a market cap of $2.44 billion; its shares were traded at around $28.68 with a P/E ratio of 23.10 and P/S ratio of 2.0.

The company reported first quarter 2014 revenue of $273.4 million compared with $276.1

615 Views    Jimmy Xiao    2014-05-27 16:32

Headlines Total 140
  • 1
  • 2

2020-07-10 $ 30.68 (-2.63%)
7:00pm
2020-07-09 $ 30.68 (-2.63%)
5:22pm
2020-07-06 $ 28.87 (-2.14%)
3:43pm
2020-06-22 $ 28.43 (-1.32%)
11:01am
2020-06-16 $ 22.75 (2.57%)
7:00am
2020-06-05 $ 19.97 (-2.49%)
7:00am
2020-06-04 $ 21.01 (-4.33%)
7:00pm
2020-05-29 $ 19.24 (-16.35%)
1:31pm
12:45pm
2020-05-28 $ 23 (-0.61%)
7:02am
2020-05-27 $ 23.14 (-2.12%)
7:03am
2020-05-22 $ 25.16 (-2.52%)
7:02pm
2020-05-14 $ 26.5 (-2.39%)
7:01pm
2020-05-12 $ 27.15 (3.15%)
7:40am
2020-05-11 $ 26.32 (29.4%)
4:37pm
9:14am
6:29am
2020-05-08 $ 20.34 (-1.88%)
7:37am
2020-05-06 $ 25.15 (230.92%)
1:24pm
7:01pm
2020-05-05 $ 7.6 (6.29%)
5:45pm
7:36am
2020-05-04 $ 7.15 (7.04%)
10:02am
2020-05-01 $ 6.68 (-7.22%)
8:57am
2020-04-30 $ 7.31 (1.11%)
7:01pm
2020-04-29 $ 7.23 (-4.74%)
7:01pm
2020-04-28 $ 7.23 (-4.74%)
7:00am
2020-04-27 $ 7.59 (4.12%)
3:00am
2020-03-05 $ 8.5 (-1.73%)
7:00pm
2020-02-27 $ 10.13 (-15.65%)
7:00am
2020-02-26 $ 10.99 (-0.72%)
7:00pm
2020-02-13 $ 10.24 (1.99%)
7:00am
2020-02-10 $ 10.06 (5.78%)
7:00am
2020-01-13 $ 11.54 (4.34%)
7:00am
2020-01-10 $ 11.38 (4.02%)
7:00pm
2019-12-19 $ 10.96 (3.59%)
3:00pm
2019-12-11 $ 9.69 (3.86%)
11:00am
2019-12-09 $ 9.83 (1.55%)
3:00pm
2019-12-02 $ 9.28 (-2.01%)
7:00am
2019-11-12 $ 8.25 (3.77%)
11:01am
2019-11-10
11:00am
2019-11-09
11:00am
7:00pm
2019-11-08 $ 8.25 (-2.02%)
3:00pm
7:00pm
7:00pm
2019-11-07 $ 8.37 (-1.53%)
7:00pm
2019-11-06 $ 8.37 (-1.53%)
11:00am
7:01pm
2019-11-05 $ 8.58 (-2.83%)
7:01pm
2019-11-04 $ 8.58 (-2.83%)
3:00pm
2019-11-01 $ 8.83 (3.88%)
3:02pm
3:01pm
11:01am
2019-10-31 $ 8.5 (-1.73%)
7:00am
7:00pm
2019-10-30 $ 8.65 (-1.59%)
3:00pm
2019-10-29 $ 8.87 (1.84%)
7:00pm
2019-10-25 $ 8.71 (-3.22%)
3:00pm
11:00am
7:00am
2019-10-24 $ 9 (-3.74%)
11:00am
7:00pm
7:00pm
2019-10-23 $ 9.35 (-15.23%)
11:01am
11:00pm
7:00pm
2019-10-22 $ 11.03 (-3.08%)
3:00pm
2019-10-19
3:00pm
2019-10-18 $ 11 (-3.93%)
3:00pm
2019-10-17 $ 11.45 (2.6%)
11:01am
2019-10-16 $ 11.16 (-2.96%)
3:00pm
11:00am
7:00am
11:00pm
7:00pm
2019-10-11 $ 11.38 (0.53%)
3:00pm
2019-10-10 $ 10.88 (-5.56%)
7:00pm
2019-10-08 $ 11.52 (-2.95%)
3:00pm
11:00pm
2019-10-04 $ 12.18 (-0.73%)
3:00pm
2019-10-02 $ 12.02 (-5.8%)
11:00pm
2019-10-01 $ 12.76 (2.57%)
11:00pm
2019-09-30 $ 12.76 (2.57%)
3:00am
2019-09-27 $ 12.44 (-0.56%)
3:00pm
2019-09-26 $ 12.51 (-3.55%)
7:00am
2019-09-24 $ 13.05 (-2.1%)
11:01am
2019-09-23 $ 13.33 (3.49%)
3:00pm
2019-09-18 $ 13.13 (-1.5%)
11:00pm
7:00pm
2019-09-17 $ 13.13 (-1.5%)
3:00am
2019-09-16 $ 13.33 (1.91%)
3:00pm
2019-09-05 $ 13.88 (1.24%)
11:00pm
2019-08-30 $ 14.47 (1.12%)
7:00pm
2019-08-28 $ 14.31 (2.58%)
3:00pm
2019-08-09 $ 14.56 (2.75%)
7:02pm
2019-08-01 $ 14.39 (-2.18%)
7:10pm
2019-07-25 $ 13.73 (-2.21%)
7:00pm
2019-07-18 $ 15.17 (-0.26%)
7:00pm
2019-07-11 $ 16.09 (-2.07%)
7:03pm
Total 140
  • 1
  • 2